Why has the accuracy of Benevolent AI's drug target prediction algorithm dropped by 15% in the past month?

Introduction

The recent 15% drop in accuracy of Benevolent AI's drug target prediction algorithm is a critical issue that demands immediate attention. This decline could significantly impact the company's core value proposition and potentially affect drug discovery timelines. I'll approach this problem systematically, focusing on identifying the root cause, validating hypotheses, and developing both short-term fixes and long-term solutions.

Step 1

Clarifying Questions (3 minutes)

• Looking at the timing, I'm thinking there might have been a recent update to the algorithm. Has there been any significant change to the model or its training data in the past month?

Why it matters: Recent changes could directly impact algorithm performance. Expected answer: Yes, there was a model update or data refresh. Impact on approach: If yes, we'd focus on the changes made; if no, we'd look at other factors.

• Considering the complexity of drug target prediction, I'm wondering about the dataset composition. Has there been any change in the types or sources of data being used for predictions?

Why it matters: Changes in data quality or composition could affect accuracy. Expected answer: No significant changes in data sources. Impact on approach: If changes occurred, we'd investigate data quality; if not, we'd look at other factors.

• Given the 15% drop, I'm curious about the baseline. What was the typical accuracy range before this decline, and how was it measured?

Why it matters: Understanding the normal variation helps determine if this is an anomaly. Expected answer: Accuracy was typically 85-90%, measured through cross-validation. Impact on approach: This would help us set realistic goals for improvement.

• Thinking about external factors, have there been any changes in the competitive landscape or industry standards for measuring accuracy?

Why it matters: External benchmarks could influence our perception of performance. Expected answer: No significant industry changes. Impact on approach: If changes occurred, we'd need to reassess our metrics; if not, we focus internally.

• Considering user feedback, have there been any reports from clients or researchers about specific types of predictions becoming less accurate?

Why it matters: User feedback could point to specific areas of decline. Expected answer: Some reports of inaccuracies in rare disease targets. Impact on approach: This would guide our investigation towards specific prediction types.